Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: geewiz who wrote (417)	12/23/1999 10:51:00 AM
From: GREG FINLEY	Read Replies (1) \| Respond to of 534

Hi Art, Just read your message from last week. I thought the deal was going to be the year end announcement, but it looks like the Malaria test is going to be it. They are doing well in Portland, and without being specific, I would look for more news before the 15th of January. I think this company is ripe to really take off. The Merck guy...I'll have to find out whether he was an adversary or an advocate in the "almost deal" with BJCT. Have a good holiday, and I look forward to further communication soon. Always, Greg